# Efficacy and Safety of High-Flow Nasal Cannula Versus Noninvasive Ventilation for Pulmonary Arterial Hypertension-Associated Acute Respiratory Failure

> **NCT06582459** · — · ACTIVE_NOT_RECRUITING · sponsor: **The First People's Hospital of Neijiang** · enrollment: 90 (estimated)

## Conditions studied

- Pulmonary Arterial Hypertension
- Acute Respiratory Failure
- High-flow Nasal Cannula
- Noninvasive Ventilation

## Interventions

- **DEVICE:** HFNC treatment
- **DEVICE:** NIV treatment

## Key facts

- **NCT ID:** NCT06582459
- **Lead sponsor:** The First People's Hospital of Neijiang
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-01-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06582459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06582459, "Efficacy and Safety of High-Flow Nasal Cannula Versus Noninvasive Ventilation for Pulmonary Arterial Hypertension-Associated Acute Respiratory Failure". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06582459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*